Home / Going-concern warnings / IN8BIO, INC.
Filed 2026-05-07 · Form 10-Q · Accession 0001193125-26-212135 nano
Price before filing: $1.58 (2026-05-06 close, split/dividend-adjusted)
Market cap at flag: $7.0M (2026-05-07) · Latest: $21.6M (2026-10-16)
| Window | INAB | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -8.9% | +0.7% | -9.6% | 2026-06-08 |
| 90 days | -37.4% | +5.2% | -42.6% | 2026-08-05 |
| 180 days | pending | pending | until 2026-11-03 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"Summary of Selected Risk Factors Associated with Our Business The following is a summary of the principal risks associated with an investment in our common stock: • There is substantial doubt regarding our ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2026-03-31)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Newsletter delivered by beehiiv. See our privacy policy.